Literature DB >> 8597841

Conjunctival biopsy in patients with Kawasaki disease.

J C Burns1, J D Wright, J W Newburger, E E Schneeberger, G W Mierau, L E Smith.   

Abstract

Kawasaki disease (KD) is an acute vasculitis of infants and young children that is associated with bilateral nonexudative conjunctivitis during the acute illness. Epidemiologic evidence has suggested an infectious cause but the etiology of KD remains unknown. We examined conjunctival biopsy specimens from seven patients with typical KD to characterize the pathologic changes during the acute disease. Light microscopic examination revealed nonspecific, mild inflammatory changes that included vascular dilatation, infiltration with scattered lymphocytes, increased numbers of plasma cells in the conjunctival stroma, and increased prominence of goblet cells in the epithelium. No pathogens were identified by special stains for bacteria and rickettsiae, nor were viral particles seen by electron microscopy. We conclude that the conjunctivitis of acute KD is characterized by vascular dilatation with a mild mononuclear cell response with no pathognomonic features. The conjunctiva can be readily sampled in these patients and biopsy may prove useful in selected patients to exclude other clinical entities in the differential diagnosis.

Entities:  

Mesh:

Year:  1995        PMID: 8597841     DOI: 10.3109/15513819509026990

Source DB:  PubMed          Journal:  Pediatr Pathol Lab Med        ISSN: 1077-1042


  2 in total

1.  Kawasaki disease as a systemic vasculitis in childhood.

Authors:  Kei Takahashi; Toshiaki Oharaseki; Yuki Yokouchi; Nobuyuki Hiruta; Shiro Naoe
Journal:  Ann Vasc Dis       Date:  2010-12-02

2.  Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease.

Authors:  Anne H Rowley; Susan C Baker; Stanford T Shulman; Linda M Fox; Kei Takahashi; Francesca L Garcia; Susan E Crawford; Pauline Chou; Jan M Orenstein
Journal:  J Infect Dis       Date:  2005-10-17       Impact factor: 5.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.